Previous small trials showed that an insulin-lowering diet significantly decreases body weight, serum testosterone, the bioavailability of both estrogens and IGF-I and the main factors of the metabolic syndrome (MS) in both healthy postmenopausal women and in BC patients [2,3]. This evidence concerns the gene INS and myeloid sarcoma.